retatrutide nash nonalcoholic fatty liver disease trial Current and future pharmacological therapies for NAFLD/NASH Retatrutide | Peak Biosciences

We must move beyond the false dichotomy of lifestyle vs

Its older counterparts GLP-1 agonist like Semaglutide and dual agonist Tirzepatide have made their way in weight loss and diabetes research

This isn't intended to be health advice, but rather to share my own experience

Some of the most common therapeutic errors involved patients taking doses too early due to perceived pen malfunctions, confusion surrounding daily versus weekly doses, incorrect amounts drawn from multi-dose vials or patients forgetting previous doses

But with those results come some aesthetic challenges: This has given rise to popular terms like "Ozempic face," which refers to the gaunt or hollow appearance some clients experience

Compounded tirzepatide requires a prescription, and injectable medication should only come through a licensed clinician and pharmacy